Viewing StudyNCT00171587



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171587
Status: COMPLETED
Last Update Posted: 2009-11-19
First Post: 2005-09-12

Brief Title: Study of the Safety Tolerability Pharmacokinetics and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Neoplasm Metastasis
Tumors
Keywords:
Name View
Histologically confirmed metastatic solid tumors View
Metastatic solid tumors View
PTK787ZK 222584 View
Vatalanib View
Capecitabine View
VEGF vascular endothelial growth factor View